Skip to main content
. 2007 Feb 7;13(5):732–739. doi: 10.3748/wjg.v13.i5.732

Figure 4.

Figure 4

A: Response rate relative to baseline (increase of ≥ 1 CSBM per week) by week (ITT population); B: Absolute response rate (increase of ≥ 3 CSBM per week) (ITT population). aP < 0.05 vs placebo; Mean number of CSBMs per week at baseline: tegaserod 0.36; placebo 0.31.